您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Enoxacin hydrate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Enoxacin hydrate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Enoxacin hydrate图片
CAS NO:84294-96-2
包装与价格:
包装价格(元)
100mg电议
500mg电议
1 g电议
5 g电议

产品名称
依诺沙星倍半水合物
Enoxacin Sesquihydrate
AT-2266 hydrate
CI-919 hydrate
产品介绍
Enoxacin hydrate (Enoxacin sesquihydrate) 是一种氟喹诺酮,可以干扰DNA复制,抑制细菌 DNA 促旋酶 (IC50=126 μg/ml) 和拓扑异构酶 IV (IC50=26.5 μg/ml)。Enoxacin hydrate 是一种miRNA加工激活剂,可增强 siRNA 介导的 mRNA 降解并促进内源性 miRNA 的生物发生,也可增强 TAR RNA 结合蛋白 2 (TRBP) 介导的 microRNA 加工。Enoxacin hydrate 有效抑制革兰氏阳性和阴性细菌, 是一种特异性的癌症生长抑制剂。
生物活性

Enoxacin hydrate (Enoxacin sesquihydrate), a fluoroquinolone, interferes withDNA replicationand inhibitsbacterialDNA gyrase (IC50=126 μg/ml) andtopoisomeraseIV (IC50=26.5 μg/ml). Enoxacin hydrate is amiRNAprocessing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin hydrate has potent activities against gram-positive and -negative bacteria. Enoxacin hydrate is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediatedmicroRNAprocessing[1][2][3][4].

IC50& Target

Quinolone

 

体外研究
(In Vitro)

Enoxacin hydrate (Enoxacin sesquihydrate) increases siGFP-mediated gene knockdown mediated by siRNA against EGFP in HEK293 cells-based reporter system in a dose-dependent manner, with a median effective concentration (EC50) of ~30 μM, whereas it has no effect on the cells expressing GFP only. Enoxacin (50 μM) promotes the processing of miRNAs and the loading of siRNA duplexes onto RISCs in HEK293 cells[3].
Enoxacin has no effect on the processing of pre-let-7 or pre-miR-30a by Dicer alone. However, the addition of Enoxacin can enhance the processing of let-7 or pre-miR-30a by Dicer and TRBP together[3].
Enoxacin inhibits 90% Escherichia coli, Klebsiella sp., Aeromonas sp., Enterobacter spp., Serratia spp., Proteus mirabilis, and Morganella morganii at less than or equal to 0.8 micrograms/ml[5].

体内研究
(In Vivo)

Enoxacin hydrate (Enoxacin sesquihydrate; 100 μM; 2 μl; injected into ear once a day for 3 consecutive days (days 12, 13 and 14)) enhances the the GFP mRNA knockdown efficiency by Lv-siGFP (from 80% to 60%; 40% GFP mRNA level remained), whereas alone has no effect on GFP expression in GFP transgenic line C57BL/6-Tg(ACTB-EGFP)1Osb/J (10 d old) with lentivirus expressing shGFP (Lv-siGFP; injected into ear for 10 days)[3].

Clinical Trial
分子量

347.34

性状

Solid

Formula

C15H17FN4O3.3/2H2O

CAS 号

84294-96-2

中文名称

依诺沙星倍半水合物

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据
In Vitro: 

1M NaOH : 100 mg/mL(287.90 mM;ultrasonic and adjust pH to 11 with NaOH)

DMSO : 2.78 mg/mL(8.00 mM;Need ultrasonic)

H2O : 1 mg/mL(2.88 mM;ultrasonic and warming and heat to 80℃)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.8790 mL14.3951 mL28.7902 mL
5 mM0.5758 mL2.8790 mL5.7580 mL
10 mM0.2879 mL1.4395 mL2.8790 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (protect from light)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。